Neurogene
NGNE
35 hedge funds and large institutions have $138M invested in Neurogene in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 7 closing their positions.
111% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 39 → 35 (-4)
19% less capital invested
Capital invested by funds: $171M → $138M (-$33.3M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$9.77M |
| 2 |
Goldman Sachs
New York
|
+$9.26M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$866K |
| 4 |
Franklin Resources
San Mateo,
California
|
+$851K |
| 5 |
RA
Royce & Associates
New York
|
+$754K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.32M |
| 2 |
VAM
Visium Asset Management
New York
|
-$956K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$753K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$506K |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$312K |
NGNE Hedge Fund Activity: Q1 2016 in Review
35 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2016, worth a combined $138M — down 19% from $171M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NGNE and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 19 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $9.77M. The largest seller was Numeric Investors, exiting entirely with an estimated $2.32M sold.
- 35 institutional investors held Neurogene (NGNE) as of Q1 2016, down from 39 in Q4 2015.
- Funds reported $138M of Neurogene stock for Q1 2016, down 19% quarter-over-quarter.
- 4 funds opened new Neurogene positions in Q1 2016 and 7 closed out, a net change of -3 holders.
- The largest Neurogene buyer in Q1 2016 was Baker Bros. Advisors, an estimated $9.77M added.
- The largest Neurogene seller in Q1 2016 was Numeric Investors, an estimated $2.32M sold.
Based on aggregated 13F filings for Q1 2016.